Hutch News
Results per Page:
Understanding the genetics of X chromosome inactivation
from the Bedalov lab, Clinical Research Division
Reawakening the X chromosome: New possible therapeutic targets for rare neurological disorder
Study points to potential reversal of rare childhood neurological disorder by reactivating silenced copy of the disease-linked gene
Dr. Antonio Bedalov wins award for translational research
Ignition Award helps to fund projects that show promise for sparking new grant applications or future pre-clinical and clinical studies
Bedalov's journey from Split to splitomicin and beyond
Toni Bedalov investigates drug candidates for anticancer therapy in breast-cancer malignancies, illuminates the molecular process of gene silencing
Breaking the Silence
Discovery could lead to new treatments for cancer, sickle-cell anemia